Electrocardiographic (ECG) Safety Study of Droxidopa at Clinical and Supratherapeutic Dose

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

June 30, 2011

Conditions

QTc Interval

Interventions

DRUG

Droxidopa

600 mg, single oral dose

DRUG

Droxidopa

2000 mg, single oral dose

DRUG

Moxifloxacin

400 mg, single oral dose

DRUG

Placebo

Placebo matching Droxidopa or Moxifloxacin

Trial Locations (1)

PPD Phase I Clinic, Austin